# Hawthorne Health

> Hawthorne Health is a clinical trials company that decentralizes research by sending GCP-trained medical professionals - called Hawthorne Heroes - directly into patients' homes, pharmacies, and community settings. Founded in 2015 by former Edwards Lifesciences executive Jodi Akin, the company operates the largest mobile nurse network in clinical research, covering 50+ states and territories, with access to over 1,000 community-based locations. Their technology platform and distributed workforce model have completed 76+ trials with a 99% visit completion rate while achieving patient diversity metrics 3-10x above industry standards.

- **Founded:** 2015
- **Headquarters:** Walnut Creek, California, United States
- **Founders:** Jodi Akin (Founder & Chairman)
- **Team size:** ~150 employees plus 4,000+ contracted Hawthorne Heroes
- **Products:** Hawthorne Cloud, Hawthorne Heroes Network, Community Site Network, Home Visit Solution
- **Notable:** Completed 76+ clinical trials since 2015, 99% visit completion rate across all trials, Collected 8M+ clinical data points

## Products & services

- **Hawthorne Cloud** — A 21CFR and GDPR-compliant technology platform for managing decentralized clinical trial workflows, data collection, and compliance.
- **Hawthorne Heroes Network** — A distributed network of 4,000+ GCP-trained medical professionals who conduct clinical trial assessments in patients' homes, pharmacies, and community settings across 50+ states.
- **Community Site Network** — A network of 75+ community-based clinical trial sites across the US, including pharmacies, patient centers, and community health locations, providing access to 50M+ patients.
- **Home Visit Solution** — In-home clinical assessments including complex procedures like echocardiograms, enabling patients to participate in trials without traveling to traditional research sites.

## Achievements

- Completed 76+ clinical trials since 2015
- 99% visit completion rate across all trials
- Collected 8M+ clinical data points
- Achieved 3x industry standard for African American enrollment (15% vs <5%) in PREVUE-VALVE study
- Achieved 10x industry standard for Hispanic enrollment (10% vs <1%) in PREVUE-VALVE study
- Recruited 1,000 patients across 48 states for valvular heart disease study
- Completed 500-patient pilot in under four months
- Built network of 4,000+ GCP-trained mobile medical professionals
- Established 75+ community-based trial sites and 1,000+ community locations
- Contributed to FDA clearance of Reflow Medical's Spur Peripheral Retrievable Stent System (2025)
- Secured strategic partnership with Labcorp, the world's largest laboratory company

## Latest updates

- **2025-06** — Contributed to FDA clearance of Reflow Medical's Spur Peripheral Retrievable Stent System through DEEPER REVEAL trial support.
- **2025-02** — Presented 'Bridging the Last Mile' at SCOPE Summit 2025 with Labcorp and RxE2.
- **2025-01** — Announced strategic partnership with RxE2 to create the largest integrated community-based clinical trial network.
- **2024-01** — Appointed Josh Rose as new CEO. Added three board members from Labcorp, CVS Health, and Northpond Ventures. Announced Labcorp strategic collaboration.
- **2023-10** — Announced monumental diversity recruitment data for PREVUE-VALVE valvular heart disease study.
- **2021-06** — Completed $20M Series A funding led by Northpond Ventures with SignalFire and P5 Health Ventures.

## Links

- Website: https://hawthornehealth.com
- LinkedIn: http://www.linkedin.com/company/hawthornehealth
- Twitter/X: http://twitter.com/@HawthorneHEROs
- Facebook: https://www.facebook.com/HawthorneHealthInc

---

Profile page: https://yespress.io/hawthorne-health-inc
Published by YesPress — https://yespress.io
Last updated: 2026-05-29